GSK scraps plan to launch oral anemia drug in EU, ceases further expansion efforts
Fierce Pharma
JULY 26, 2023
Despite a positive opinion from local drug reviewers, GSK has decided not to bring its FDA-approved oral anemia drug daprodustat to Europe—or any additional countries for that matter.
225 
Let's personalize your content